Modulation of angiogenesis by dithiolethione‐modified NSAIDs and valproic acid

[1]  A. Sparatore,et al.  Anti-inflammatory and gastrointestinal effects of a novel diclofenac derivative. , 2007, Free radical biology & medicine.

[2]  J. Wallace,et al.  5-Amino-2-hydroxybenzoic Acid 4-(5-Thioxo-5H-[1,2]dithiol-3yl)-phenyl Ester (ATB-429), a Hydrogen Sulfide-Releasing Derivative of Mesalamine, Exerts Antinociceptive Effects in a Model of Postinflammatory Hypersensitivity , 2006, Journal of Pharmacology and Experimental Therapeutics.

[3]  S. Flis,et al.  Antiangiogenic effect of sulindac sulfide could be secondary to induction of apoptosis and cell cycle arrest. , 2006, Anticancer research.

[4]  Jeannette Bigler,et al.  Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics , 2006, Nature Reviews Cancer.

[5]  Napoleone Ferrara,et al.  Angiogenesis as a therapeutic target , 2005, Nature.

[6]  Peter Carmeliet,et al.  Angiogenesis in life, disease and medicine , 2005, Nature.

[7]  Y. Cao,et al.  Tumor angiogenesis and therapy. , 2005, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[8]  D. Wink,et al.  Thrombospondin-1 inhibits endothelial cell responses to nitric oxide in a cGMP-dependent manner. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[9]  Y. Surh,et al.  Nrf2 as a novel molecular target for chemoprevention. , 2005, Cancer letters.

[10]  S. Chaufour,et al.  Hsp27 consolidates intracellular redox homeostasis by upholding glutathione in its reduced form and by decreasing iron intracellular levels. , 2005, Antioxidants & redox signaling.

[11]  H. Waldmann,et al.  Inhibition of Angiogenesis‐Relevant Receptor Tyrosine Kinases by Sulindac Analogues , 2005, Chembiochem : a European journal of chemical biology.

[12]  H. Cai,et al.  Role of CaMKII in hydrogen peroxide activation of ERK1/2, p38 MAPK, HSP27 and actin reorganization in endothelial cells , 2004, FEBS letters.

[13]  Samuel A. Santoro,et al.  Endorepellin causes endothelial cell disassembly of actin cytoskeleton and focal adhesions through α2β1 integrin , 2004, The Journal of cell biology.

[14]  C. Harris,et al.  Hypoxic inducible factor 1α, extracellular signal-regulated kinase, and p53 are regulated by distinct threshold concentrations of nitric oxide , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Peter Carmeliet,et al.  Manipulating angiogenesis in medicine , 2004, Journal of internal medicine.

[16]  S. Loitsch,et al.  Modulation of angiogenesis-related protein synthesis by valproic acid. , 2004, Biochemical and biophysical research communications.

[17]  S. Gately,et al.  Multiple roles of COX-2 in tumor angiogenesis: a target for antiangiogenic therapy. , 2004, Seminars in oncology.

[18]  R. Busse,et al.  Valproic acid inhibits angiogenesis in vitro and in vivo. , 2004, Molecular pharmacology.

[19]  S. Libutti,et al.  Angiogenesis inhibitors target the endothelial cell cytoskeleton through altered regulation of heat shock protein 27 and cofilin. , 2003, Cancer research.

[20]  P. O'dwyer,et al.  Role of the AP-1 element and redox factor-1 (Ref-1) in mediating transcriptional induction of DT-diaphorase gene expression by oltipraz: a target for chemoprevention. , 2003, Biochemical pharmacology.

[21]  J. Spławiński,et al.  Anti-angiogenic and apoptotic effects of metabolites of sulindac on chick embryo chorioallantoic membrane. , 2003, Hybridoma and hybridomics.

[22]  B. Weinstein,et al.  In vivo imaging of embryonic vascular development using transgenic zebrafish. , 2002, Developmental biology.

[23]  V. Steele,et al.  A quantitative angiogenesis model for efficacy testing of chemopreventive agents. , 2001, Anticancer research.

[24]  M. Kwak,et al.  Role of phase 2 enzyme induction in chemoprotection by dithiolethiones. , 2001, Mutation research.

[25]  A. Logan,et al.  Angiogenesis , 1993, The Lancet.

[26]  B. Böttcher,et al.  ber Trithione, V. Mitteil. Notiz ber einige neue Trithione) , 1951 .

[27]  H. Verheul,et al.  Angiogenesis inhibitors: what is the clinical future? , 2005, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.

[28]  B. Ruggeri,et al.  The chemopreventive agent oltipraz possesses potent antiangiogenic activity in vitro, ex vivo, and in vivo and inhibits tumor xenograft growth. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[29]  M. Christen,et al.  Anethole dithiolethione regulates oxidant-induced tyrosine kinase activation in endothelial cells. , 2000, Antioxidants & redox signaling.

[30]  T. Kensler,et al.  Chemoprotection by Organosulfur Inducers of Phase 2 Enzymes: Dithiolethiones and Dithiins , 2000, Drug metabolism and drug interactions.

[31]  J. Landry,et al.  Regulation of actin dynamics by stress-activated protein kinase 2 (SAPK2)-dependent phosphorylation of heat-shock protein of 27 kDa (Hsp27). , 1999, Biochemical Society symposium.

[32]  K. Helzlsouer,et al.  Mechanisms of chemoprotection by oltipraz , 1992, Journal of cellular biochemistry. Supplement.